Entera Bio Broadcasts Pricing of $10.0 Million Direct Funding by way of BVF Companions with Possible for as much as $24.5 Million in Overall Proceeds
TEL AVIV, Israel, April 02, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd.…
Entera Bio Proclaims Complete Yr 2025 Monetary Effects and Supplies Industry Updates
EB613, the primary oral anabolic (bone development) peptide pill for postmenopausal ladies…
